BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 26/11/2004

New Animal Drugs; Monensin

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Elanco Animal Health. The supplemental NADA provides for use of monensin Type A medicated articles to formulate Type B and Type C medicated feeds used for increased milk production efficiency in dairy cows.

Source: Federal Register — Food and Drug AdministrationOpen original release →